Dr. Roger Andersen, MD, MPH
Dr. Andersen manages Ondine’s regulatory and clinical programs, working extensively with the FDA, Health Canada, and the EU to obtain regulatory approvals. Prior to joining the company, he practiced as a physician and surgeon in Seattle and directed a clinical research organization for pharmaceutical and medical device clinical trials.
Photodisinfection Therapy: Essential Technology for Infection Control
Peer Reviewed
Click Here for Print Version
Abstract
Photodisinfection therapy (PDT) is a treatment modality that involves the administration of a light-sensitive compound, known as a...
